Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CorMedix Inc. Director's Dealing 2012

Apr 13, 2012

32333_dirs_2012-04-13_80d8fffd-4ab7-4b1f-9744-09aeb0b2ba18.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2012-04-12

Reporting Person: PHARMABIO DEVELOPMENT INC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-12 Common Stock, $0.001 par value per share S 11000 $.45 Disposed 778563 Direct